Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 116 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1151 10.3 months Metastatic NSCLC 4 Chemotherapy
Penn State Hershey Medical Center, Penn State Cancer Institute United States 11/2008
Treatment Details: Patients: This phase 3 study involved 80 patients with metastatic or advanced-stage non-small cell lung cancer. There were similar numbers of men (53% of patients) and women (47%) in this s
 
1152 10.3 months Advanced NSCLC 5 Chemotherapy
S. Luigi Hospital Italy 7/2008
Treatment Details: Patients: This study involved patients with advanced non-small cell lung cancer (NSCLC). Patients were divided into two separate treatment groups. Group A consisted of 862 patients with a
 
1153 10.3 months Advanced NSCLC 5 Chemotherapy
S. Luigi Hospital Italy 7/2008
Treatment Details: Patients: This study involved patients with advanced non-small cell lung cancer (NSCLC). Patients were divided into two separate treatment groups. Group A consisted of 862 patients with a
 
1154 10.3 months NSCLC 4 Chemotherapy
Hellenic Oncology Research Group Greece 11/2010
Treatment Details: Patients: Non-small cell lung cancer patients in this phase 3 study were divided into two treatment groups. Group 1 consisted of 67 patients with a median age of 62 years, 95.5% of whom we
 
1155 10.2 months Melanoma 5 Biologic therapy
The Angeles Clinic and Research Institute United States 8/2010
Treatment Details: Patients: This study involved 155 melanoma patients who have received prior treatment. The median patient age was 59 years and 52% were male. Treatment: Patients in this study were tre
 
1156 10.2 months GBM 4 Chemotherapy
Norris Cotton Cancer Center United States 11/2008
Treatment Details: Patients: This phase 2 study involved twenty-six patients with glioblastoma multiforme. Their median age was 55, ranging from 30 to 75. Treatment: Patients were treated with the chemoth
 
1157 10.2 months Hormone-refractory prostate cancer 5 Chemotherapy
Hotel-Dieu de France University Hospital Lebanon 2/2008
Treatment Details: Patients: This phase II study involved twenty seven men with metastatic prostate cancer. The median age was 68, ranging from 53 to 83 years. The majority (89%) had metastasis to the bone.
 
1158 10.2 months Newly diagnosed GBM 4 Chemotherapy
Radiation
University of California San Francisco United States 1/2001
Treatment Details: Patients: This study included 231 patients with newly diagnosed glioblastoma multiforme. (Six patients were later determined to have a gliosarcoma.) The patients were divided into four tre
 
1159 10.2 months Metastatic, castration-resistant prostate cancer 5 Biologic therapy
Chemotherapy
Hormone
University of Paris Sud France 11/2011
Treatment Details: Patients: This study involved patients with metastatic castration-resistant prostate cancer who received prior docetaxel-based chemotherapy. The patients were divided into two separate tre
 
1160 10.2 months Metastatic melanoma 4 Immunotherapy
Human Immune Therapy Center, University of Virginia United States 8/2013
Treatment Details: Patients: This phase 2 study involved metastatic melanoma patients who were divided into four separate treatment groups. Group A had 47 patients with a median age of 65 years; 56.1% were m
 
Page 116 of 187  | Previous Page  | Next Page